USD 7.24 billion
Report ID:
SQMIG35A2292 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
61
|Figures:
75
Nasal Cannula Market size was valued at USD 7.24 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 11.82 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).
The global nasal cannula market has witnessed significant growth and advancements in recent years. Nasal cannulas are widely used medical devices that deliver supplemental oxygen to patients who have difficulty breathing or require respiratory support. The market is driven by various factors, including the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea.
Additionally, an aging population, increasing healthcare expenditure, and the growing demand for home healthcare services further contribute to market growth. Technological advancements have led to the development of innovative nasal cannulas with improved comfort, better oxygen delivery efficiency, and enhanced patient compliance. Moreover, the COVID-19 pandemic has further boosted the demand for nasal cannulas, especially for patients with respiratory complications. The market is characterized by the presence of several key players who are actively engaged in research and development activities to introduce novel products and gain a competitive edge. Geographically, North America dominated the global nasal cannula market, attributed to the high prevalence of respiratory disorders and favorable reimbursement policies. However, the Asia Pacific region is expected to witness significant growth in the forecast period due to the increasing healthcare infrastructure, rising awareness about respiratory diseases, and improving access to healthcare services. Overall, the global market is projected to continue its upward trajectory in the coming years, driven by technological advancements, increasing respiratory disorders, and the growing need for efficient respiratory care solutions.
Global Market Size
USD 7.24 billion
Largest Segment
Low flow
Fastest Growth
Low flow
Growth Rate
6.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Nasal Cannula Market is segmented by type, application, and region. Based on type, the market can be segmented into Low Flow and high flow. Based on application, the market is segmented into Hospitals, ambulatory health services, long term care centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Nasal Cannula Market Analysis by Type
The dominant segment in the global nasal cannula market is the low flow segment. Low flow nasal cannulas are commonly used for delivering a precise and controlled amount of oxygen to patients with respiratory conditions. They are cost-effective and suitable for patients who require lower levels of oxygen supplementation. Low flow nasal cannulas are widely adopted in various healthcare settings, including hospitals, clinics, and homecare, contributing to their dominance in the market.
The fastest-growing segment in the global nasal cannula market is the high flow segment. High flow nasal cannulas provide a significantly higher flow rate of oxygen compared to low flow cannulas. They are increasingly being used in critical care settings, such as intensive care units (ICUs) and emergency departments, for patients with severe respiratory conditions or acute respiratory distress. The high flow nasal cannulas offer benefits such as improved patient comfort, better humidification, and reduced work of breathing. The growing demand for advanced respiratory support systems and the increasing prevalence of respiratory disorders are driving the rapid growth of the high flow nasal cannula segment in the market.
Nasal Cannula Market Analysis by Application
The dominant segment in the global nasal cannula market based on application is hospitals. Nasal cannulas are extensively used in hospitals for various respiratory conditions and procedures. Hospitals have well-established healthcare infrastructure, a large patient population, and a wide range of respiratory care needs, making them the primary users of nasal cannulas. The demand for nasal cannulas in hospitals is driven by the need for supplemental Hyperbaric oxygen therapy, post-surgical care, emergency situations, and critical care settings.
The fastest-growing segment in the global nasal cannula market based on application is ambulatory health services. Ambulatory health services include outpatient clinics, diagnostic centers, and home healthcare services. The increasing trend towards outpatient care, technological advancements in portable oxygen delivery systems, and the growing preference for home healthcare are fueling the demand for nasal cannulas in ambulatory health services. Nasal cannulas offer convenience, mobility, and flexibility in delivering oxygen therapy outside of traditional hospital settings. The expansion of ambulatory health services and the rising focus on patient-centric care contribute to the rapid growth of the nasal cannula market in this segment.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the global nasal cannula market. North America holds a significant market share due to factors such as a high prevalence of respiratory diseases, well-established healthcare infrastructure, and favorable reimbursement policies. The region is characterized by the presence of key market players, technological advancements, and a strong focus on improving respiratory care, which contributes to its dominance in the nasal cannula market.
Asia Pacific is the fastest-growing segment in the global nasal cannula market. The Asia Pacific region is experiencing rapid market growth due to several factors, including a large population base, increasing healthcare expenditure, and rising awareness about respiratory diseases. Moreover, the improving healthcare infrastructure, expanding access to healthcare services, and growing demand for home healthcare solutions further drive the market's growth in this region. The Asia Pacific region is witnessing a surge in respiratory disorders, leading to a higher demand for nasal cannulas and respiratory care devices, thus making it the fastest-growing market segment.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Nasal Cannula Market Drivers
Increasing prevalence of respiratory diseases
Nasal Cannula Market Restraints
Availability of alternative respiratory support devices
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global nasal cannula market is characterized by intense competition among various players striving to gain a significant market share. These players focus on product development, technological advancements, and strategic collaborations to enhance their product offerings and expand their geographic presence. Key strategies employed in the market include mergers and acquisitions, partnerships, and product launches to stay competitive. Additionally, companies are investing in research and development activities to introduce innovative nasal cannula designs with improved comfort, efficiency, and patient compliance. The market's competitive dynamics are driven by factors such as pricing strategies, brand recognition, distribution channels, and regulatory compliance to meet the evolving needs of healthcare professionals and patients.
Nasal Cannula Market Top Player’s Company Profiles
Nasal Cannula Market Recent Developments
Smiths Medical unveils the OptiflowTM 5 HFNC system in November 2023. It is intended for use with patients of all ages.
The Arrow® HFNC Optiflow® Comfort cannula, which has a soft, flexible shape for better patient comfort, is introduced by Teleflex Medical in November 2023.
In November 2023, a fresh study on the worldwide burden of chronic respiratory disorders is released by the World Health Organization (WHO), emphasizing the necessity of better access to oxygen therapy.
Medtronic announces the release of the new Puritan BennettTM HFNC 900+ system in October 2023, which has improved features for patient comfort and care.
October 2023 The Philips Respironics Trilogy Evo Mobile oxygen concentrator system gets authorized by the US Food and Drug Administration (FDA) for use in HFNC therapy.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global nasal cannula market analysis, the market is experiencing significant growth driven by factors such as the increasing prevalence of respiratory diseases, rising demand for oxygen therapy, and advancements in healthcare infrastructure. The market is segmented into low flow and high flow nasal cannulas, with low flow cannulas dominating the market and high flow cannulas emerging as the fastest-growing segment. Hospitals are the dominant application segment, while ambulatory health services are witnessing rapid growth. North America holds a significant market share, while the Asia Pacific region is experiencing substantial growth. The competitive landscape is characterized by intense competition among key players, who focus on product development and strategic collaborations. Despite alternative respiratory support devices posing a restraint, the market is expected to continue its upward trajectory driven by technological advancements and increasing respiratory disorders.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 7.24 billion |
Market size value in 2031 | USD 11.82 billion |
Growth Rate | 6.4% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Nasal Cannula Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Nasal Cannula Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Nasal Cannula Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Nasal Cannula Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2292
sales@skyquestt.com
USA +1 351-333-4748